Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Tons of news coming from the nation’s capitol as Democrats set their agenda for next year, but it’s worth highlighting what else happened yesterday. Epic officials publicly addressed whether their business practices choke innovation, as detailed in a STAT investigation. What did they say? Scroll down. As White House pulls Heidi Overton nomination, what’s next for the FDA? After the White House pulled its nomination of Heidi Overton for commissioner of the Food and Drug Administration on Tuesday evening, the future of the agency that oversees $4.1 trillion worth of food, tobacco, and medical products is extremely unsettled. The agency’s current acting commissioner, Kyle Diamantas, has reportedly said he’s uninterested in taking the role permanently, and even indicated he doesn’t want to stay at the FDA past the new year. Meanwhile, it is very unlikely that Congress has enough time to install another nominee before January, meaning that Senate Democrats will have final say over the next commissioner. Who in the White House tanked Overton’s nomination? Who will replace her? Some people have suggested Sen. Roger Marshall of Kansas, or even a little-known guy named Marty Makary. (The former FDA head did not respond to request for comment.) Where does this leave the agency? STAT’s Margaret Manto breaks it down. Sanders’ “Medicare for All” plan Sen. Bernie Sanders (I-Vt.) is feeling optimistic about the first stage of his plan to vastly expand health coverage in the U.S. He predicted at a Wednesday press conference that Democrats will pass legislation lowering the Medicare eligibility age while President Trump is still in office, and that Trump might not veto it. Sanders would like Congress to lower the Medicare eligibility age from 65 to 55, expand coverage to include dental, vision, and hearing care, and guarantee free Medicaid coverage to children until age 19. And he pushed back on the assumption that Trump would veto such a bill. “I am not absolutely certain that Trump would not sign it,” he said. The health committee does not have jurisdiction over Medicare, but Sen. Ron Wyden (D-Ore.), who is expected to lead the committee that does, said he is on board with Sanders’ plan. Rep. Hakeem Jeffries (D-N.Y.) also supports the “Medicare for More” and “Medikids” proposals, an indication the party’s liberal and moderate wings are quickly moving toward common ground on a health care agenda. Sanders also offered insights into the health care investigations he might undertake, including of health secretary Robert F. Kennedy Jr. and the insurance and pharma industries. “Taking a hard look at the way the insurance industry runs, how they distort health care. Taking a hard look at the pharmaceutical industry as to why we pay by far the highest prices in the world for prescription drugs. Those are areas that need investigation,” he said. — John Wilkerson Why Cassidy rejected Trump’s pick to lead NSF Less than two months before he leaves office, Bill Cassidy took a stand. The Republican senator from Louisiana rejected Jim O’Neill as the nominee to lead the National Science Foundation, cancelling the vote to confirm him over doubts about his willingness to stand up for scientific integrity. The high-ranking health official had previously served at the Department of Health and Human Services and Centers for Disease Control and Prevention under health secretary Kennedy. But O’Neill “did not do enough to stand up for science and against irresponsible decisions and statements” from Kennedy in those roles, Cassidy said at a meeting of his committee. More from my STAT colleagues on Cassidy’s bold move as his time in the Senate runs out. Epic responds to antitrust allegations, promises more open ecosystem At a panel discussion at HLTH, a health technology conference in Las Vegas, Epic’s executives for the first time responded directly to a STAT investigation that found the company is undercutting competition by selectively withholding data access needed by rival application developers. Officials at Epic, the largest maker of electronic health records, defended against allegations of anticompetitive conduct and said they are seeking to build a more open ecosystem amid a deluge of requests for integration coming from third-party software vendors. They also said the company would make it easier for companies to use AI to read data stored in the company’s platforms. Lots more juicy details from this panel, moderated by Brittany Trang. Read more. $10 million In the wake of the midterm elections, leaders of the Make America Healthy Again movement have said that their candidates were up against opponents with massive funding advantages. But filings show that the movement’s political arm had more than $10 million to spend during this election cycle. Instead of directing those funds to promising candidates, it funneled millions to allies, associated organizations, and pundits. One notable example: The PAC spent less than $50,000 on a California House race it called “the most direct ideological confrontation between the movement and its institutional opposition anywhere on the 2026 ballot.” It spent more money this cycle at Mastro’s Steakhouse D.C., a white-tablecloth spot that offers $110 porterhouse steaks. Another great story from our DC team. Influential preventive services panel to meet for first time in over a year Later this morning, a little-known but influential panel that recommends which preventive services must be covered by insurance will meet for the first time in more than a year, writes STAT’s Chelsea Cirruzzo. The U.S. Preventive Services Task Force will review recommendations related to cervical cancer, perinatal depression, and unhealthy alcohol use in teens and adults, all of which have not been updated in at least five years, and have been awaiting finalization since last year, when Kennedy canceled the group’s meetings and overhauled its membership. Read more from Chelsea Cirruzzo about the meeting and some of the new members’ conflict of interests. What we’re reading NIH to move last group of its research chimps to a sanctuary, STAT California insurer pushes subscription model for GLP-1 drugs, Bloomberg How a multimillion-dollar donation led Mount Sinai to a ‘high-risk’ hire, Politico Pennsylvania’s growing costs to contain measles outbreak, Axios
Sanders’ ‘Medicare for All’ plan accrues more liberate and moderate support in Congress
Full Article
Original Source
Read the full article at Statnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.